TL;DR
This study identifies a circular RNA, circ_0000098, that is significantly downregulated in hepatocellular carcinoma (HCC). The researchers demonstrate that circ_0000098 acts as a sponge for miR-1204, thereby upregulating ALX4 expression and suppressing tumor growth, migration, and invasion in HCC. This discovery sheds light on a novel regulatory mechanism in HCC and suggests circ_0000098 as a potential therapeutic target.
What Problem Does This Paper Address?
Hepatocellular carcinoma (HCC) remains a major global health challenge, with treatment outcomes often unsatisfactory. While circular RNAs (circRNAs) are known to play roles in cancer progression, their specific functions and mechanisms in HCC are not fully understood. This paper aims to elucidate the role of a particular circRNA, circ_0000098, in HCC pathogenesis and to uncover its underlying molecular mechanism. Specifically, the study investigates how circ_0000098 might influence HCC cell behavior and whether it acts as a competitive endogenous RNA (ceRNA) to regulate other molecules involved in cancer progression.
Methods
The researchers employed a multi-pronged approach to investigate circ_0000098's function:
- Bioinformatics Analysis: They utilized the Gene Expression Omnibus (GEO) database (GSE97332) and the GEO2R tool to identify differentially expressed circRNAs in HCC tissues compared to normal adjacent tissues.
- Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR): This standard technique was used to measure the expression levels of circ_0000098, miR-1204, and ALX4 mRNA in tissues and cell lines.
- Cellular Assays:
- Cell Counting Kit-8 (CCK-8): To assess cell proliferation.
- Scratch Wound Healing Assay: To evaluate cell migration.
- Transwell Assay: To measure cell migration and invasion.
- Western Blot: To determine the protein levels of key markers like ALX4, E-cadherin, N-cadherin, and Vimentin, which are involved in epithelial-mesenchymal transition (EMT).
- Molecular Mechanism Studies:
- Dual-Luciferase Reporter Assay: To confirm the direct binding between miR-1204 and circ_0000098, as well as between miR-1204 and ALX4.
- RNA Immunoprecipitation (RIP) Assay: To further validate the interaction between circ_0000098 and miR-1204.
- Subcellular Localization Analysis: To determine where circ_0000098 is primarily located within HCC cells.
- Actinomycin D Assay: To assess the stability of circ_0000098.
- In Vivo Study: A lung metastasis model in nude mice was established to investigate the role of circ_0000098 in metastasis.
Datasets
- GEO database (GSE97332): This dataset provided microarray data of circRNAs from 7 pairs of human HCC tumor tissues and matched adjacent normal tissues. This was used for initial screening of differentially expressed circRNAs.
- Human HCC Tissues and Matched Adjacent Tissues: 34 pairs of HCC tissues and adjacent tissues were collected from patients undergoing surgery for further analysis.
- Human HCC Cell Lines: HepG2, SNU423, SNU475, Huh7, and SMMC-7721 cell lines were used for in vitro experiments.
- Normal Hepatocyte Line: HL-7702 cell line was used as a control.
Key Insights and Ideas
- Circ_0000098 as a Tumor Suppressor in HCC: The study reveals that circ_0000098 is significantly downregulated in HCC tissues and cells, and its low expression is associated with larger tumor size. This positions it as a potential tumor suppressor.
- Circ_0000098 Inhibits Malignant Behaviors: Knockdown of circ_0000098 promotes proliferation, migration, invasion, and EMT in HCC cells, while its overexpression has the opposite effect. This highlights its critical role in controlling aggressive HCC phenotypes.
- The ceRNA Mechanism: Circ_0000098 acts as a molecular sponge for miR-1204. By binding to miR-1204, it prevents miR-1204 from interacting with its targets, thus indirectly regulating gene expression.
- ALX4 as a Downstream Target: ALX4 is identified as a direct target of miR-1204. miR-1204 negatively regulates ALX4 expression, and consequently, circ_0000098, by sponging miR-1204, positively regulates ALX4.
- The Circ_0000098/miR-1204/ALX4 Axis: The study establishes a novel regulatory axis where circ_0000098 upregulates ALX4 by sequestering miR-1204, thereby inhibiting HCC progression.
- Inhibition of Metastasis: The in vivo study demonstrated that knockdown of circ_0000098 significantly promoted lung metastasis in mice, further supporting its tumor-suppressive role.
Key Results
- Expression Levels: Circ_0000098 expression was significantly lower in HCC tissues and cell lines compared to normal controls. Conversely, miR-1204 expression was elevated in HCC. ALX4 expression was found to be downregulated in HCC tissues and cells.
- Functional Impact: Knockdown of circ_0000098 significantly increased proliferation, migration, and invasion of Huh7 and SMMC-7721 cells. Overexpression of circ_0000098 had the opposite effect.
- EMT Markers: Knockdown of circ_0000098 led to decreased E-cadherin and increased N-cadherin and Vimentin expression, indicative of EMT.
- Molecular Interactions: Dual-luciferase reporter assays and RIP assays confirmed the direct binding of miR-1204 to circ_0000098 and miR-1204 to ALX4.
- Correlation: Circ_0000098 expression was negatively correlated with miR-1204 and positively correlated with ALX4 expression in HCC tissues.
- In Vivo Metastasis: Mice injected with circ_0000098-knockdown Huh7 cells showed significantly more severe lung metastasis compared to the control group.
Limitations and Future Work
- Mechanism of Dysregulation: While the study shows circ_0000098 is downregulated in HCC, the precise mechanism driving this dysregulation remains unclear.
- Sample Size: The study acknowledges that the sample size for patient cohorts was relatively small. Future work should involve larger cohorts from diverse medical centers to validate the significance of circ_0000098, miR-1204, and ALX4 as biomarkers.
- Serum Biomarker Potential: The study notes that while serum miR-1204 has been linked to prognosis in breast cancer, its association with HCC prognosis requires further investigation.
- Therapeutic Potential: The findings suggest circ_0000098 as a potential therapeutic target, but further research is needed to explore its clinical applicability.
Summary updated